Valuation: Guided Therapeutics, Inc.

Market Cap 2.8Cr 2.43Cr 2.27Cr 2.07Cr 3.9Cr 267.19Cr 3.97Cr 27Cr 10Cr 133.75Cr 11Cr 10Cr 446.17Cr P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 3.09Cr 2.68Cr 2.51Cr 2.29Cr 4.3Cr 294.64Cr 4.37Cr 30Cr 12Cr 147.49Cr 12Cr 11Cr 492.01Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
1 week-21.03%
Current month-23.67%
1 month-23.67%
3 months-0.43%
6 months-28.44%
Current year-57.59%
1 week 0.2
Extreme 0.2
0.29
1 month 0.2
Extreme 0.2
0.3
Current year 0.17
Extreme 0.17
0.54
1 year 0.15
Extreme 0.15
0.54
3 years 0.06
Extreme 0.064
0.54
5 years 0.06
Extreme 0.062
0.78
10 years 0.02
Extreme 0.0206
3,200
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Date Insider Type Main position Quantity % Market Cap.
25/02/26 Others

Director

260 25.3411%
25/02/26 Option

Chairman

6,00,000 0.7177%
25/02/26 Fiscal year

Director

84,77,131 10.1402%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-21.03%+17.44%+34.71% 2.8Cr
-1.18%+2.74%+22.92%+9.58% 22TCr
-0.92%+1.96%-2.51%-20.17% 14TCr
0.00%+7.37%-16.81%+31.78% 14TCr
+0.53%+4.85%-49.57%+1.29% 7.45TCr
-0.53%+3.63%+19.16%+16.56% 5.36TCr
+0.03%-0.15%-16.01%-17.27% 5.01TCr
+0.71%+5.62%+24.11%+17.68% 4.19TCr
-0.63%+3.46%+39.31%+41.78% 4.09TCr
+2.09%+4.95%-2.04%+3.07% 3.26TCr
Average +0.21%+3.54%+3.60%+11.90% 8.03TCr
Weighted average by Cap. -0.20%+3.83%+1.80%+7.96%

Financials

2024 2025
Net sales 7T 6.07T 5.69T 5.19T 9.76T 7L 9.91T 66.97T 26.15T 3L 26.28T 25.71T 11.16L 8L 7L 6L 6L 10.69L 7.32Cr 10.86L 73.38L 28.65L 3.66Cr 28.8L 28.17L 12Cr
Net income -24.17L -20.95L -19.64L -17.91L -33.69L -23Cr -34.23L -2.31Cr -90.28L -12Cr -90.74L -88.78L -39Cr -31.96L -27.7L -25.97L -23.68L -44.55L -31Cr -45.27L -3.06Cr -1.19Cr -15Cr -1.2Cr -1.17Cr -51Cr
Net Debt 17.71L 15.35L 14.39L 13.12L 24.69L 17Cr 25.08L 1.69Cr 66.15L 8.46Cr 66.49L 65.05L 28Cr 28.76L 24.93L 23.37L 21.31L 40.09L 27Cr 40.74L 2.75Cr 1.07Cr 14Cr 1.08Cr 1.06Cr 46Cr
Logo Guided Therapeutics, Inc.
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
3
Date Price Change Volume
13/26/13 $0.2900 -.--% 3,162
  1. Stock Market
  2. Stocks
  3. GTHP Stock